Table 1.
Characteristics of 121 patients with invasive ovarian carcinomas
| Parameter | All cases (%) |
|---|---|
| Age at surgery (years) | |
| < 60 | 73 (60.3) |
| ≥ 60 | 48 (39.7) |
| Histological type | |
| serous | 80 (66.1) |
| non-serous | 29 (24.0) |
| undifferentiated | 12 (9.9) |
| FIGO stage | |
| I | 18 (14.9) |
| II | 10 (8.3) |
| III | 84 (69.4) |
| IV | 9 (7.4) |
| Tumor stage | |
| pT1 | 21 (17.3) |
| pT2 | 12 (10.0) |
| pT3 | 88 (72.7) |
| Nodal stage (n = 96) | |
| pN0 | 46 (47.9) |
| pN1 | 50 (52.1) |
| Tumor grade (Silverberg) | |
| G1 | 19 (15.7) |
| G2 | 50 (41.3) |
| G3 | 52 (43.0) |
| Intraoperative residual tumor (n = 88) | |
| residual tumor < 2 cm | 78 (88.6) |
| residual tumor ≥ 2 cm | 10 (11.4) |
| Chemotherapy (n = 113) | |
| Platinum-based | 106 (93.8) |
| non-platinum | 3 (2.7) |
| no chemotherapy | 4 (3.5) |